Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission
|
|
- Helen Barber
- 6 years ago
- Views:
Transcription
1 Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission Presented at: Post G8 Briefing: Future Financing To Address The Global HIV/AIDS Epidemic Washington, DC July 21, 2005 Jennifer Kates Vice President and Director, HIV Policy Henry J. Kaiser Family Foundation
2 Chart 1 Acknowledgments & Methodology Data originally presented at: The Long-Term Financing Implications of the HIV/AIDS Pandemic: Building the International Effort to Deliver Resources Meeting convened by the Kaiser Family Foundation, the Royal African Society, and the Overseas Development Institute at Marlborough House, London, June 30, 2005 Data collected and analyzed as part of collaborative effort between UNAIDS and the Kaiser Family Foundation Direct data collection during first half of 2005 from G7 and EC governments and other DAC Members Other major data sources include: The Global Fund; UN agencies; OECD CRS, NIDI RFP Data for some governments are preliminary estimates Included are both funding commitments and disbursements for HIV/AIDS in 2004 (by donor FY) For Donor Governments, captures bilateral assistance and Global Fund contributions, representing prevention, care, and support; funding for international HIV research not included Global Fund contributions adjusted to represent an estimated HIV/AIDS share (60%)
3 Chart 2 G7 as Percent of Official Development Assistance (ODA), 2004 Other DAC 28% G7 72% $78.6 billion Notes: Data are preliminary only. Figure includes aid provided to the European Union (EU) by the four G7 members who are also part of the EU. Source: OECD, April 11, 2005
4 Chart 3 Total G7/EC and Other Donor Government Commitments for HIV/AIDS, 2004 Bilateral Commitments & Global Fund* Contributions US$ Billions $3.6 $2.7 $0.86 Total Bilateral Global Fund* Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria.
5 Chart 4 G7/EC as Combined Share of Total HIV/AIDS Commitments by Donor Governments, 2004 Bilateral Commitments & Global Fund* Contributions Other DAC, 13% G7/EC, 87% $3.6 billion Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria.
6 Chart 5 G7/EC as Share of Total HIVAIDS Commitments by Donor Governments, 2004 Bilateral Commitments & Global Fund* Contributions Japan, 4.1% Italy, 0.4% U.K., 16.6% Germany, 4.2% France, 3.9% U.S., 45.4% EC, 7.7% Canada, 5.3% Other DAC, 13.2% $3.6 billion Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria.
7 Chart 6 G7/EC as Share of Bilateral Commitments and Disbursements for HIV/AIDS, by Donor, 2004 Commitments Disbursements Japan, 3.5% Italy, 0.5% U.K., 20.5% U.S., 49.6% Japan, 4.4% Italy, 0.6% Germany, 4.6% U.K., 22.2% U.S., 40.3% Germany, 3.5% France, 1.2% France, 0.9% EC, 4.3% Canada, 4.1% Other DAC, 13.1% EC, 5.5% Canada, 5.7% Other DAC, 15.5% $2.7 billion $1.9 billion Notes: Funding for HIV/AIDS research not included data for the U.K. and France are preliminary. Data for Japan, Austria, Belgium, Denmark, Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Disbursement data based on donor reports, analysis of government documents, and historical data. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria.
8 Chart 7 G7/EC as Share of Global Fund* HIV/AIDS Contributions by Donor Governments, 2004 Germany, 3.2% France, 13.2% EC, 18.5% Italy, 0.0% U.S., 32.2% Japan, 6.0% U.K., 4.2% Canada, 9.1% Other DAC, 13.6% $856 million Notes: *Global Fund contribution adjusted to represent HIV/AIDS share (60%). Italy s contribution to Global Fund for FY 2004 not yet provided, but primary channel of funding for Italy is through Global Fund. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria.
9 Chart 8 G7/EC Funding Channels for HIV/AIDS Commitments, by Donor, 2004 Global Fund Adjusted to Represent Estimated HIV/AIDS Share 24% 41% 57% 22% 35% 6% 17% 25% 81% 100% Global Fund Bilateral 76% 59% 43% 78% 65% 94% 83% 75% 19% Total Canada EC France Germany Italy Japan U.K. U.S. Other DAC Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Italy s contribution to Global Fund for FY 2004 not yet provided, but primary channel of funding for Italy is through Global Fund. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria.
10 Chart 9 Assessing Fair Share Complex, no single methodology Many important questions about what to take into account Must look at multiple methods, such as: Rank by total commitment; Rank by share of commitment compared to share of the global economy or share of developed country GDP; Rank by value of commitment compared with standardized measure of relative wealth, such as commitment per $1 million GDP or GNI; Share of total compared to the cost-sharing distribution negotiated for United Nations Member States. No one measure alone can answer the question
11 Chart 10 Example 1: Rank by Share of Total HIV/AIDS Commitments by Donor Governments, 2004 Bilateral Commitments & Global Fund* Contributions U.S. U.K. EC Canada Japan France Germany Italy Other DAC 16.6% 7.7% 5.3% 4.1% 3.9% 3.5% 0.4% 13.2% 45.4% Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria.
12 Chart 11 Example 2: Rank by Total HIV/AIDS Commitment per US$1 Million, Gross National Income (GNI) Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. GNI data imputed from: OECD, April Japan adjusted to represent average GNI. Other DAC governments not included in GNI analysis Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria. Bilateral Commitments & Global Fund* Contributions U.K. $274 Canada $194 U.S. $137 France Germany Japan $46 $33 $69 Italy $8
13 Chart 12 Example 3: Share of Global Resources Available for HIV/AIDS Compared to Share of World GDP, 2004 Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Disbursement data based on donor reports, analysis of government documents, and historical data. GDP data from: International Monetary Fund, World Economic Outlook Database, April 2005 Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; UNAIDS/PCB(14)/03, Conference Paper 2a, June 2003; UNAIDS/PCB(14)/03.3, April 29, 2003; The Global Fund to Fight AIDS, Tuberculosis and Malaria. Bilateral Disbursements & Global Fund* Contributions U.S. Japan Germany U.K. France Italy Canada 17.4% 11.5% 2.3% 6.7% 1.9% 5.2% 7.7% 5.0% 2.2% 4.1% 0.2% 2.4% 3.1% 28.9% Share of World GDP Share of Global HIV/AIDS Resources
14 Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Disbursement data based on donor reports, analysis of government documents, and historical data. GDP data from: International Monetary Fund, World Economic Outlook Database, April 2005 Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; UNAIDS/PCB(14)/03, Conference Paper 2a, June 2003; UNAIDS/PCB(14)/03.3, April 29, 2003; The Global Fund to Fight AIDS, Tuberculosis and Malaria. Chart 13 Example 4: Share of Donor Government Resources Available for HIV/AIDS Compared to Share of Advanced Economies GDP, 2004 Bilateral Disbursements & Global Fund* Contributions U.S. Japan Germany 14.5% 4.9% 8.4% 4.2% 36.4% 37.8% Share of Advanced Economies GDP U.K. France 6.6% 6.3% 4.9% 16.7% Share of Donor Government HIV/AIDS Resources Italy 5.2% 0.4% Canada 3.1% 6.7%
15 Chart 14 But is the Need Being Met? Resources Available Compared to Estimated Need Notes: Includes bilateral assistance and Global Fund contributions. *Global Fund contributions adjusted to represent an HIV/AIDS share (60%). Greece, Luxembourg, Netherlands, New Zealand, Norway, Portugal and Spain estimated based on 2003 data. Disbursement data based on donor reports, analysis of government documents, and historical data. Sources: UNAIDS & Kaiser Family Foundation Analysis, June 2005; The Global Fund to Fight AIDS, Tuberculosis and Malaria; UNAIDS, 2004 Report on the Global AIDS Epidemic, July 2004; UNAIDS, Resource Needs for an Expanded Response to AIDS in Low and Middle Income Countries, PCB17 Conference Paper, June 27-29, 2005 Additional Gap to be Filled 2004 Gap 2004 Resources Available, All Sources $8.3 billion $15 billion $22 billion
16 The Henry J. Kaiser Family Foundation 2400 Sand Hill Road Menlo Park, CA Phone: (650) Fax: (650) Washington Office: 1330 G Street, NW Washington, DC Phone: (202) Fax: (202) Additional copies of this publication (#7347) are available on the Kaiser Family Foundation's website at The Kaiser Family Foundation is a non-profit, private operating foundation dedicated to providing information and analysis on health care issues to policymakers, the media, the health care community, and the general public. The Foundation is not associated with Kaiser Permanente or Kaiser Industries.
Key Highlights continued
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation),
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments, 2006 Authors: Jennifer Kates (Kaiser Family Foundation),
More informationFinancing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011 Authors: Jennifer Kates (Kaiser Family Foundation), Adam Wexler (Kaiser Family
More informationFinancing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010 Authors: Jennifer Kates (Kaiser Family Foundation), Adam Wexler (Kaiser Family
More informationDonor Government Funding for HIV in Low- and Middle-Income Countries in 2016
REPORT Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016 July 2017 Prepared by: Jen Kates & Adam Wexler Kaiser Family Foundation and Eric Lief Consultant and UNAIDS Donor government
More informationSurvey of G7 Nations on HIV Spending in Developing Countries
Chartpack The Kaiser Family Foundation Survey of G7 Nations on HIV Spending in Developing Countries July 2005 Methodology The Kaiser Family Foundation Survey of G7 Nations on HIV Spending in Developing
More informationDonor Government Funding for HIV in Low- and Middle-Income Countries in 2017
July 2018 Donor Government Funding for HIV in Low- and Middle-Income Countries in 2017 Jen Kates & Adam Wexler Kaiser Family Foundation and Eric Lief Georgetown University, Center for Global Health Science
More informationFinancing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission
Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission july 2005 Jennifer Kates Kaiser Family Foundation FINANCING THE RESPONSE
More informationFinancial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment
Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment Joint WHO & UNAIDS Consultation with Pharmaceuticals and Stakeholders November 05 2012 Lara Stabinski, MD, MPH Medical
More informationINTERNATIONAL ASSISTANCE FOR HIV/AIDS IN THE DEVELOPING WORLD: TAKING STOCK OF
INTERNATIONAL ASSISTANCE FOR HIV/AIDS IN THE DEVELOPING WORLD: TAKING STOCK OF THE G8, OTHER DONOR GOVERNMENTS, AND THE EUROPEAN COMMISSION The report was prepared by: Jennifer Kates, Vice President and
More informationMonitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators
Monitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators José Antonio Izazola Chief, AIDS Financing and Economics Division Evidence, Monitoring and Policy Department UNAIDS Assessment 6.3
More informationDevelopment assistance for HIV/AIDS, tuberculosis and malaria by channel
Chapter 6: Distribution of development assistance for health Building a foundation of knowledge that accurately accounts for the volume of global health funding is crucial, both for those who give aid
More informationGlobal Funding for HIV/AIDS in Resource Poor Settings
Global Funding for HIV/AIDS in Resource Poor Settings Todd Summers Progressive Health Partners Jennifer Kates Kaiser Family Foundation December 2003 Global Funding for HIV/AIDS in Resource Poor Settings
More informationNational Surveys of Women s Health Care Providers and the Public: Views and Practices on Medical Abortion THE KAISER FOUNDATION FAMILY
Chartpack September 24, 2001 THE KAISER FAMILY FOUNDATION National Surveys of Women s Health Care Providers and the Public: Views and Practices on Medical Abortion Methodology The Kaiser Family Foundation
More informationAUGUST 200 JULY Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act:
Reauthorization of PEPFAR, The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act: JULY 2008 AUGUST 200 A Side-by-Side Comparison to Current Law Reauthorization of PEPFAR, The United
More informationCRS Report for Congress
Order Code RS21181 Updated February 23, 2005 CRS Report for Congress Received through the CRS Web HIV/AIDS International Programs: Appropriations, FY2003-FY2006 Raymond W. Copson Specialist in International
More informationPost-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division
Post-2015: Innovative Financing of HIV/AIDS Travis Mitchell Economic Affairs Division High Burden (HIV/AIDS) Low Income countries will remain dependent on external funding for decades, creating major financial
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More information1. Global Fund on HIV/AIDS, Tuberculosis and Malaria
1. Global Fund on HIV/AIDS, Tuberculosis and Malaria Commitment We will work with other donors and stakeholders in the effort to secure funds needed for the 2006-2007 replenishment period and call upon
More informationOverview of development assistance for health trends
Chapter 1 Overview of development assistance for health trends This chapter uses estimates of development assistance for health (DAH) produced by the Institute for Health Metrics and Evaluation (IHME)
More informationU.S. Funding for International Family Planning & Reproductive Health
April 2016 Issue Brief U.S. Funding for International Family Planning & Reproductive Health SUMMARY The U.S. government has supported international family planning and reproductive health (FP/RH) efforts
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationWESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
More informationFilling the Funding Gap to Save Lives
Filling the Funding Gap to Save Lives A Proposal for an Equitable Contributions Framework for the Global Fund 1 October 9, 2002, Global Day of Action on the Global Fund "To succeed, the amount of money
More informationHAS DONOR PRIORITIZATION OF HIV/AIDS CONTROL DISPLACED AID FOR OTHER HEALTH CAUSES?
HAS DONOR PRIORITIZATION OF HIV/AIDS CONTROL DISPLACED AID FOR OTHER HEALTH CAUSES? DRAFT ONLY: PLEASE DO NOT CITE WITHOUT PERMISSION OF THE AUTHOR Jeremy Shiffman, Ph.D. Associate Professor of Public
More informationCase study examining the impact of German reunification on life expectancy
Supplementary Materials 2 Case study examining the impact of German reunification on life expectancy Table A1 summarises our case study. This is a simplified analysis for illustration only and does not
More informationRESOURCE NEEDS FOR AN EXPANDED RESPONSE TO AIDS IN LOW AND MIDDLE INCOME COUNTRIES. Presented at the Programme Coordinating Board
RESOURCE NEEDS FOR AN EXPANDED RESPONSE TO AIDS IN LOW AND MIDDLE INCOME COUNTRIES Presented at the Programme Coordinating Board Seventeenth meeting Geneva, 27-29 June 2005 AIDS Resource Needs Estimation
More informationThe Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals
The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act: A Side-by-Side Comparison of Current Law and Reauthorization Proposals june 2006 Jennifer Kates Kaiser Family Foundation The Ryan White
More informationAIDS Funding Landscape in Asia and the Pacific
Agenda 3: Country experiences and plans towards sustainable AIDS financing AIDS Funding Landscape in Asia and the Pacific J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in
More informationIMPACT OF DEVELOPMENT ASSISTANCE FOR HEALTH ON COUNTRY SPENDING
CHAPTER 4: IMPACT OF DEVELOPMENT ASSISTANCE FOR HEALTH ON COUNTRY SPENDING As external health aid has grown in importance in recent years, global health experts have discussed the role that development
More informationCurrent levels and recent trends in health inequalities in the EU: Updates from the EU Report
Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Anne Scott London Health Observatory Expert Working Group on Social Determinants and Health Inequalities Luxembourg,
More informationGlobal Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group
Global Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group 6 May 2015 Geneva Frederic Goyet, External Relations
More informationWhat Is the Future of HIV Funding? Presented by the Kaiser Family Foundation and Funders Concerned About AIDS December 8, 2017
What Is the Future of HIV Funding? Presented by the Kaiser Family Foundation and Funders Concerned About AIDS December 8, 2017 Jen Kates Vice President and Director of Global Health and HIV Policy Kaiser
More informationThe U.S. President s Emergency Plan for AIDS Relief (PEPFAR)
The U.S. President s Emergency Plan for AIDS Relief (PEPFAR) Although the U.S. has been involved in efforts to address the global AIDS crisis since the mid-1980s, the creation of the President s Emergency
More informationType 1 Diabetes Australian Research Impact Analysis
Type 1 Diabetes Australian Research Impact Analysis Executive Overview Summary Type 1 diabetes research in Australia Australia is making a significant contribution to the quantity and quality of the global
More informationThomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.
European Comparative Alcohol Study Europe and Alcohol Policy Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.BO 220 FIN-00531
More informationBLACK RESIDENTS VIEWS ON HIV/AIDS IN THE DISTRICT OF COLUMBIA
PUBLIC OPINION DISPARITIES & PUBLIC OPINION DATA NOTE A joint product of the Disparities Policy Project and Public Opinion and Survey Research October 2011 BLACK RESIDENTS VIEWS ON HIV/AIDS IN THE DISTRICT
More informationOUTLOOK EXAMINES MAKING SENSE OF THE MONEY + WHERE DOES THE MONEY FOR AIDS GO?
OUTLOOK EXAMINES MAKING SENSE OF THE MONEY + WHERE DOES THE MONEY FOR AIDS GO? 4 OUTLOOK unaids.org SPECIAL SECTION MAKING SENSE OF THE MONEY OUTLOOK makes the case for the necessities of life. unaids.org
More informationGLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW
GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW TOWARDS AN CURE PEOPLE FOCUSED SCIENCE DRIVEN JULY 2018 A GLOBAL STRATEGIC APPROACH TOWARDS
More informationThis brief analyses investments by OECD Development Assistance Committee (DAC) donors in six policy areas
Financing the unfinished business of gender equality and women s rights: priorities for the post-215 framework March 214 This brief analyses investments by OECD Development Assistance Committee (DAC) donors
More informationCRS Report for Congress
CRS Report for Congress Received through the CRS Web Order Code RS21181 Updated May 2, 2003 HIV/AIDS International Programs: Appropriations, FY2002 - FY2004 Raymond W. Copson Specialist in International
More informationManuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal
Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging
More informationNATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program
NATIONAL COST OF OBESITY SEMINAR Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program 1 INTRODUCTION According to the Center of Disease Control and Prevention, the American society
More informationRequest for Letters of Intent. International Development of H5N1 Influenza Vaccines
Request for Letters of Intent International Development of H5N1 Influenza Vaccines The World Health Organization (WHO) intends to provide funding to developing (1) country vaccine manufacturers to develop
More informationPROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name
PROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name HIV/AIDS Project Region AFRICA Sector Health (60%); Other social services (23%); General public administration sector (10%);Central
More informationThe OECD Health Care Quality Indicators Project
The OECD Health Care Quality Indicators Project Ed Kelley, Ph.D. Head, OECD Health Care Quality Indicators Project Health Systems Working Party Luxembourg - April 26, 2005 1 Broad aims of the OECD s HCQI
More informationOverview of development assistance for health trends
Chapter 1: Overview of development assistance for health trends Since the inception of the first edition of Financing Global Health in 29, IHME has released up-to-date annual estimates of DAH from 199
More information39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016
8 December 2016 39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland 6-8 December 2016 Decisions The UNAIDS Programme Coordinating Board, Recalling that all aspects of UNAIDS work
More informationHIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview
HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview Prepared by The Henry J. Kaiser Family Foundation for Southern States Summit
More informationProgramme of Action for Cancer Therapy PACT. PROGRAMME OF ACTION FOR CANCER THERAPY
Programme of Action for Cancer Therapy PACT pact@iaea.org http://cancer.iaea.org PROGRAMME OF ACTION FOR CANCER THERAPY Since 1980 the IAEA has invested US $202 million to establish safe and effective
More information508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender
An overview of suicide statistics This document summarises information about suicide deaths in New Zealand covering up to 13. It does not attempt to explain causes of suicidal behaviour or causes of changes
More informationReflecting on ten years of progress in the fight against AIDS, TB and malaria
Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:
More informationRenewing Momentum in the fight against HIV/AIDS
2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationDrug Money: the illicit proceeds of opiates trafficked on the Balkan route. Executive summary
Drug Money: the illicit proceeds of opiates trafficked on the Balkan route Executive summary 2015 Executive summary The cultivation, production and trafficking of illicit opiates accounted for almost
More informationTEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée
Teddy Network of Excellence Annagrazia ALTAVILLA TEDDY Task-force in Europe for Drug Development for the Young Ph.D. Sciences Ethics LL.M. Health Law Associated Senior Lecturer Université de la MéditerranM
More informationDEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION
DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people
More informationThe road towards universal access
The road towards universal access JAN 2006 Issues Paper Requests... that the UNAIDS Secretariat and its Cosponsors assist in facilitating inclusive, country-driven processes, including consultations with
More informationSmokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
More informationJUNE 2000 HEALTH NEWS INTEREST INDEX
Toplines KAISER FAMILY FOUNDATION American Views on the AIDS Crisis in Africa: A National Survey June 2000 Methodology The Kaiser Family Foundation American Views on the AIDS Crisis in Africa: A National
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationD7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationD7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationGLP in the European Union Ecolabel detergents, GLP and accreditation
GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European
More informationTransmission, processing and publication of HBS 2015 data
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-4: Income and living conditions; Quality of life Doc. LC-ILC/194/17/EN estat.f.4 (2017) WORKING GROUP ON INCOME AND LIVING CONDITIONS
More informationCHARTING THE COURSE FOR CANADA S NATIONAL DEMENTIA STRATEGY PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE
CHARTING THE COURSE FOR CANADA S NATIONAL DEMENTIA STRATEGY PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE AUGUST 4, 2017 Alzheimer Society of Canada 2018 Pre-Budget Submission
More informationMENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa
MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with
More informationUK bowel cancer care outcomes: A comparison with Europe
UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The
More informationIARC A UNIQUE AGENCY. Cancer research for cancer prevention
IARC A UNIQUE AGENCY Cancer research for cancer prevention Director s message IARC is a unique organization. For the past 50 years, the Agency has been making important contributions to the global fight
More informationEradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011
Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 Why? Polio Crippled for life Primarily affects children We have a historic opportunity. Preventable with vaccine 1955: polio
More informationThe Global Fund & UNICEF Partnership
The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and
More informationFacilitating Access to Mental Health Services: A Look at Medicaid, Private Insurance, and the Uninsured
June 2017 Fact Sheet Facilitating Access to Mental Health Services: A Look at Medicaid, Private Insurance, and the Uninsured In 2015, over 43 million adults had a mental illness and nearly 10 million had
More informationECDC s role in the fight against HIV/AIDS in Europe
European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November
More informationA matter of life or death
w o r l d vision in t e r n a t i o n a l po l i c y briefing, G8 Summit, Japan, 2008 A matter of life or death How 18 million children are relying on the G8 to keep its promises a policy briefing and
More informationNATIONAL SURVEY OF YOUNG ADULTS ON HIV/AIDS
NATIONAL SURVEY OF YOUNG ADULTS ON HIV/AIDS Kaiser Family Foundation November 30, 2017 Introduction More than three and a half decades have passed since the first case of AIDS. An entire generation has
More informationPlace matters: why cities are key to ending AIDS
Place matters: why cities are key to ending AIDS Cities for Social Transformation Towards Ending AIDS 20 th International AIDS Conference Melbourne, Australia 19 July 2014 Steven J. Kraus Director UNAIDS
More informationAlcohol Prevention Day
Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in
More informationThe Global Picture in Blood Transfusions: A Quick Overview
The Global Picture in Blood Transfusions: A Quick Overview Jim MacPherson President & CEO MacPherson Strategies jim@macphersonstrategies.com +1 202 468 6548 24 March 2017 WHO 2016 Of the 113 million blood
More informationNational Survey of Teens and Young Adults on HIV/AIDS
Topline Kaiser Family Foundation National Survey of Teens and Young Adults on HIV/AIDS November 2012 This National Survey of Teens and Young Adults on HIV/AIDS was designed and analyzed by public opinion
More informationFAO of the UN, WHO and OIE with the collaboration of UNSIC and UNICEF. Background Paper
FAO of the UN, WHO and OIE with the collaboration of UNSIC and UNICEF Background Paper 3.4 d Ensuring intergovernmental support to national and other stakeholders for integrated action to tackle HPAI and
More informationDeliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society
Deliverable Grant Agreement number: 611742 Project acronym: PASTEUR4OA Project title: Open Access Policy Alignment STrategies for European Union Research Funding Scheme: FP7 CAPACITIES Science in Society
More informationBiology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationGlobal Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015
Page 1 5/18/2015 An Analysis of Global Trade in Lightweight paper, coated with inorganic substances, used for writing etc., of which more than 10% by weight of total fibre content consists of fibres obtained
More informationMeasles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
More informationUnited Nations Population Fund
United Nations Population Fund The Graduate Institute - Geneva March 2016 Alfonso Barragues, Deputy Director UNFPA Geneva What is UNFPA? UNFPA is an international development agency whose aim is to deliver
More informationThis technical paper analyses investments by OECD Development Assistance Committee (DAC) donors in six
Financing the unfinished business of gender equality and women s rights: priorities for the post-215 framework TECHNICAL BRIEF March 214 This technical paper analyses investments by OECD Development Assistance
More informationTHE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
More informationIOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President
IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos Jonathan Hughes IOSH Vice President About the Institution of Occupational Safety and Health (IOSH) www.iosh.co.uk
More informationThe power of innovation to save lives
Innovative Finance The power of innovation to save lives May 2013 The challenge Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.
More informationU.S. Response to the Global Threat of HIV/AIDS: Basic Facts
U.S. Response to the Global Threat of HIV/AIDS: Basic Facts Alexandra E. Kendall Analyst in Global Health February 22, 2011 Congressional Research Service CRS Report for Congress Prepared for Members and
More informationSTRATEGIC PLAN AGAINST VIRAL HEPATITIS IN SENEGAL ( ) POLICY BRIEF
PROGRAMME NATIONAL DE LUTTE CONTRE LES HEPATITES STRATEGIC PLAN AGAINST VIRAL HEPATITIS IN SENEGAL (2019-2023) POLICY BRIEF 1 INVESTING IN THE FIGHT AGAINST HEPATITIS B AND C IN SENEGAL NATIONAL STRATEGIC
More informationCONCEPT NOTE. Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems
CONCEPT NOTE Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems Official event in the programme of the Estonian Presidency of the Council of the European Union Co-organised
More informationExtrapolation and potential impact of IPHS deployment in Europe
SIMPHS2 Validation Workshop Brussels, 31 Jan 2012 1 SIMPHS2 Validation Workshop Extrapolation and potential impact of IPHS deployment in Europe JRC IPTS IS Unit Ioannis Maghiros, Fabienne Abadie, Maria
More informationEPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets
EPIDEMIOLOGY Accurate, in-depth information for understanding and assessing targeted markets WHY ACCURATE MARKET FORECASTS Start with accurate understanding Epidemiology is the study of disease patterns
More informationReady, Willing, and Able? Challenges Faced by Countries Losing Global Fund Support
D r a f t D i s c u s s i o n P a p e r Ready, Willing, and Able? Challenges Faced by Countries Losing Global Fund Support Updated: July 30, 2015 224 WEST 57 th St., New York, NY 10019 T EL 1-212-548-0600
More informationCross Border Genetic Testing for Rare Diseases
Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic
More information